Deep dive on DPP-4 inhibitors with a focus on Trajenta® (linagliptin)
This eLearning module and the associated videos have been commissioned and funded by Boehringer Ingelheim. The module and associated videos contain promotional content. For UK healthcare professionals.
View Trajenta® (linagliptin) prescribing and adverse event reporting information for Great Britain or Northern Ireland
View Jardiance® (empagliflozin) prescribing and adverse event reporting information for Great Britain or Northern Ireland
PC-GB-104526 July 2021
Malnutrition: prevention, under-recognised, and under-treated—how are you managing your patients?
This webinar has been commissioned and funded by Alliance Pharma plc and developed in partnership with Guidelines in Practice.
Information intended for UK healthcare professionals only.
JB-001309 December 2021
Management of Colitis in primary care – A practical approach
This promotional webinar has been commissioned by Ferring Pharmaceuticals and developed in partnership with Guidelines in Practice.
Information intended for UK healthcare professionals only.
View Cortiment® (budesonide MMX) prescribing information
View Pentasa® (mesalazine) prescribing information
UK-COR-2200006 January 2022
Disease-modifying anti-rheumatic drugs (DMARDS) guidelines: a focus on methotrexate guidance in clinical practice
Information intended for UK healthcare professionals only. This webinar was initiated and commissioned by Accord-UK Ltd and developed in partnership with Guidelines in Practice.
View Methofill® (methotrexate) pre-filled injector and pre-filled syringe prescribing information and adverse event reporting information here
View the Summary of Product Characteristics for Folic Acid 5mg Tablets; Legal Cat POM; NHS List price 90p
UK-02645
Date of preparation: September 2021
The importance of inhaler choice
Information intended for UK healthcare professionals only. This promotional webinar was commissioned and funded by Boehringer Ingelheim and developed in partnership with Guidelines in Practice.
View prescribing information here.
PC-GB-104812
Date of preparation: June 2021
Cow’s Milk Allergy (CMA) and The Allergic March
This promotional animation has been commissioned and funded by Reckitt and developed in partnership with Guidelines in Practice.
RB-R-9342 November 2021
Managing iron deficiency anaemia
Information intended for UK healthcare professionals only. These promotional videos have been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines and Guidelines Live. Promotional information regarding Norgine Pharmaceutical Limited products will be presented.
View FERACCRU® (ferric maltol) prescribing information and adverse event reporting information here
UK-HAE-FER-2200013
Date of preparation: May 2022
Five things you need to know about… liver function tests (part 2)
Dr Jez Thompson highlights five things you need to know about liver function tests in two new videos
Five things you need to know about… liver function tests (part 1)
Dr Jez Thompson highlights five things you need to know about liver function tests in two new videos
In conversation: barriers to implementation of the NHS restructure and future opportunities
In the final In conversation video on the NHS restructure, Dr Karen Kirkham and Dr Anthony Cunliffe explore barriers to the success of the changes
In conversation: potential benefits of the NHS restructure for practice and patients
In the second In conversation video on the NHS reorganisation, Dr Karen Kirkham and Dr Anthony Cunliffe talk about the emerging benefits of the changes
Otigo® (phenazone/lidocaine hydrochloride) 40 mg/10 mg/g ear drops, solution
Information intended for UK healthcare professionals only. This formulary decision guide was developed from content provided by LogixX Pharma Limited in a format developed by Guidelines in Practice. Renascience Pharma Limited carried out full medical approval to ensure compliance with regulations.
View Otigo® (phenazone/lidocaine hydrochloride) prescribing information and adverse event reporting information here
OTI-UK-028-SP
Date of preparation: June 2022
Sixmo®▼ (buprenorphine) 74.2 mg implant
Information intended for UK healthcare professionals only. This formulary decision guide was developed from content provided by Accord Healthcare Limited in a format developed by Guidelines in Practice.
View prescribing information and adverse event reporting information.
UK-03417
Date of preparation: October 2021
Ipinnia® XL (ropinirole hydrochloride) prolonged-release tablets
This formulary decision guide was commissioned by Ethypharm and developed from content provided by Ethypharm in a format developed by Guidelines in Practice.
View prescribing and adverse event reporting information
For UK healthcare professionals only.
UK-IPN-13 Date of preparation: September 2021
Xaggitin XL (methylphenidate hydrochloride) prolonged-release tablets
This formulary decision guide was commissioned by Ethypharm and developed from content provided by Ethypharm in a format developed by Guidelines in Practice.
View prescribing and adverse event reporting information
For UK healthcare professionals only.
UK-XAG-20 Date of preparation: July 2021
Patient consultation guide—supporting the management of patients with osteoporosis
This promotional supplement has been commissioned by Amgen and developed in partnership with Guidelines in Practice. Information for UK healthcare professionals only.
View Prolia® (denosumab) prescribing and adverse event reporting information
GB-PRO-0222-00034 March 2022
Identification and management of colitis in primary care—practical tips and considerations
This supplement has been commissioned and funded by Ferring Pharmaceuticals and developed in partnership with Guidelines in Practice.
View prescribing and adverse event reporting information for Cortiment® (budesonide) and Pentasa® (mesalazine)
UK-GAS-2100137 December 2021
Overcoming challenges in managing obesity in primary care
Information intended for UK healthcare professionals only. This supplement has been funded through an arm’s-length sponsorship by Novo Nordisk Limited. Guidelines in Practice approached Novo Nordisk Limited to fund the production of the supplement.
Date of preparation: December 2021
The unrecognised epidemic of vitamin D deficiency in Black, Asian and Minority Ethnic (BAME) groups: a consensus document
Information intended for UK healthcare professionals only. This supplement has been commissioned and funded by STADA incorporating Thornton & Ross, who provided the content.
TR-088d Date of preparation: August 2021
Guideline for the managed introduction of biosimilar bolus insulin in individuals with type 2 diabetes
This working party guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Sanofi Ltd
Showcasing local best practice in diabetes
This Guidelines in Practice supplement aims to showcase local best practice in the diagnosis and management of diabetes. The supplement includes articles from three local initiatives that have developed their own guidance or demonstrated improvements in different areas of diabetes care:
Identification and management of patients with malnutrition
This supplement has been commissioned and funded by Alliance Pharmaceuticals Ltd and developed in partnership with Guidelines in Practice.
Guideline for the managed introduction of biosimilar basal insulin
This working party guideline was developed by a multidisciplinary expert panel: Down S et al with the support of a grant from Mylan.
Implementing the NICE guideline on the management of acne vulgaris
Information intended for UK healthcare professionals only.
Implementing the Guidelines algorithm on managing obesity in primary care
Guidelines in Practice approached Novo Nordisk Ltd for an educational grant to support the production of an implementation checklist. Information intended for UK healthcare professionals only.
Date of preparation: January 2021
Dr Christos Kasparis–sponsored lunchtime symposium: Clearing the Emollient Fog
This video has been commissioned and funded by L’Oréal Active Cosmetics and developed in partnership with Guidelines Live.
January 2022
Sponsored symposium: An Algorithm approach to Showcasing Management of Hepatic Encephalopathy from Secondary to Primary Care – Dr Richard Aspinall
This video has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines Live.
View TARGAXAN® (rifaximin-α) adverse event reporting and prescribing information
UK-HEP-XIF-2200002 | March 2022
Sponsored symposium: Recent Guidelines for the Management of Iron Deficiency Anaemia in Primary Care – Dr Sophie Nelson
This video has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines Live.
View FERACCRU® (ferric maltol) adverse event reporting and prescribing information
UK-HAE-FER-2200003 | March 2022